טוען...

Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair

CRISPR/Cas9-mediated gene editing of human hematopoietic stem cells (hHSCs) is a promising strategy for the treatment of genetic blood diseases through site-specific correction of identified causal mutations. However, clinical translation is hindered by low ratio of precise gene modification using t...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Stem Cells
Main Authors:	Lomova, Anastasia, Clark, Danielle N., Campo-Fernandez, Beatriz, Flores-Bjurström, Carmen, Kaufman, Michael L., Fitz-Gibbon, Sorel, Wang, Xiaoyan, Miyahira, Eric Y., Brown, Devin, DeWitt, Mark A., Corn, Jacob E., Hollis, Roger P., Romero, Zulema, Kohn, Donald B.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	2018
נושאים:	Article
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6368869/ https://ncbi.nlm.nih.gov/pubmed/30372555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.2935
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Improving Gene Editing Outcomes in Human Hematopoietic Stem and Progenitor Cells by Temporal Control of DNA Repair

פריטים דומים